• Trial Talks Podcast
  • COVID-19
  • Blog
  • Client Login


The Future of RTSM: Insights and Forecasting with RTSM-Expert, Ian Davison

The Future of RTSM Home By all expert accounts, 2022 is the year that we can begin seeing the societal shift from late-stage pandemic to early-stage endemic as the world learns to live with the short- and long-term effects of COVID-19. Clinical trial operations, specifically as they relate to randomization and trial supply, have undergone one